Wikipedia -WSS

Wikipedia

author：focus 2025-08-11 05:32:31 - browse：869

Moderna's mResvia vaccine — The FDA has approved Moderna’s RSV vaccine for older adults. Moderna

The Food and Drug Administration on Friday approved Moderna’s vaccine to protect older adults against respiratory syncytial virus, or RSV, making this the company’s second licensed product.

The Moderna RSV vaccine, which will be marketed under the name mResvia, was approved for adults 60 and older. It is made using the same messenger RNA platform as Moderna’s other licensed product, its Covid-19 vaccine Spikevax.

“The FDA approval of our second product, mResvia, builds on the strength and versatility of our mRNA platform,” Moderna CEO Stéphane Bancel said in a statement.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： Congress gives doctors Medicare pay bump

hotspot

WSS

Change Healthcare cyberattack outage could last weeks

2 million sign

Kristina Burow of ARCH Venture Partners shares her next big bets STAT

Why getting cancer drugs just got harder for rural patients

Adele warns fans about throwing things at performers onstage

'Insanity': 4th of July mass shootings across US kill 13, injure more than 80

entertainment

Wikipedia

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Wikipedia

New air purifier tech could be key to improving indoor air quality

Philadelphia mass shooting: Few answers in apparently random attack as suspect charged with murder

Sports medicine is finally prioritizing gender equality

5 shark bites reported on Long Island as officials deploy surveillance drones

Activists slam private health insurers over coverage restrictions

Biotech companies concerned about China biosecurity crackdown

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

A bus careens into a gulch in southern Mexico, leaving 27 people dead

The cancer drug shortage isn’t new — and neither are the solutions

An inside look at PIPEs, biotech's buzzy new financing tool

knowledge

FogPharma raises $145 million in rare Series E round

Suspect in Ukraine detonates explosives at a courthouse, killing himself and wounding 2 officers

Myanmar's Supreme Court hears arguments in 2 appeals by ousted leader Aung San Suu Kyi

ALS groups 'won't be played again' by the FDA, drug sponsors

Supreme Court shows surprising restraint in chaotic year of crises: ANALYSIS

Why getting cancer drugs just got harder for rural patients

explore

hotspot

focus

explore